**To the Editor**We read with interest the recent study about the clinical characteristics of*Stenotrophomonas maltophilia* bacteremia by Ebara et al. in volume 56, issue 2 of *Internal Medicine* ([@B1]). The authors showed that the prognosis of patients who received appropriate antimicrobial therapy such as trimethoprim-sulfamethoxazole, minocycline or fluoroquinolones was poorer-though not to a significant degree-in comparison to patients who received nonspecific therapy. However, we are concerned about the timing of starting appropriate antimicrobial therapy. The treatment of *S. maltophilia* is generally challenging because of the bacterium\'s inherent resistance to multiple classes of antibiotics, including beta-lactams, carbapenems and aminoglycosides ([@B2]). In Japan, beta-lactams and carbapenems are preferred as empiric therapy, and a delay in administering appropriate therapy can lead to a poor prognosis. Uehara et al. reported that Gram staining of blood cultures could help in selecting appropriate antimicrobials for patients with positive blood cultures ([@B3]). However, the presence of *S. maltophilia* is seldom suspected; most cases are thought to be *Pseudomonas aeruginosa* or a non-fermenting bacterium. We evaluated the Gram staining results of 27 cases of *S. maltophilia* bacteremia and found that only one case was reported to be "suspected *S. maltophilia*", while "*P. aeruginosa* or other non-fermenting bacteria" was reported in six cases ([@B4]). In the remaining 20 cases, other Gram-negative bacteria, such as *Enterobacteriaceae* were reported and inappropriate therapy was continued based on the Gram staining results. Furthermore, appropriate antimicrobial therapy was not initiated in most cases of *S. maltophilia* bacteremia before making the final identification or obtaining the susceptibility testing results. This delay may also be a risk factor for a poor prognosis ([@B5]). Thus, we recommend that the authors include the timing for initiating appropriate antimicrobial therapy after blood culturing in their retrospective analysis.
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